登录 | 注册    关注公众号  
微信公众号
搜索
 >  Antibody>C-MET >HGS-S303

Recombinant Monoclonal Anti-C-MET Antibody, Rabbit (1A1)

描述/背景(Background)

MET is a tyrosine kinase receptor for the hepatocyte growth factor. It is linked to functions such as cell proliferation, scattering, morphogenesis, and survival. Ligand binding at the cell surface induces autophosphorylation of MET that provides docking sites for downstream signaling molecules. After activation of the ligand, MET interacts with the PI3-kinase subunit PIK3R1, PLCG1, SRC, GRB2, and STAT3. There interactions lead to the activation of signaling cascades including RAS-ERK, PI3, kinase-AKT, and PLCgamma-PKC. MET plays a role in embryonic development including gastrulation, development of muscles and neurons, angiogenesis, and kidney formation.

种属(Host Species)

Rabbit

克隆号(Clone)

1A1

适用方法(Application)

IHC

效价(Property)

1:1000

状态(State)

Liquid

阳性对照(Positive Control)

Human Placenta Tissue

克隆类型(Clonality)

Monoclonal

分子别名(Synonym)

C-MET

研究领域(Research Field)

Cancer Drug Targets

抗体来源(Source)

Rabbit

同种型(Isotype)

IgG

储存(Storage)

Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle.

 

典型数据(Typical Data)

质控样本(Control Sample)

C-MET CONTROL SAMPLE

Immunohistochemical analysis of paraffin embedded Human placenta tissue labelled with HGS-S303 at 1/1000 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

肿瘤样本(Cancer Sample)

C-MET CANCER SAMPLE

C-MET CANCER SAMPLE

C-MET CANCER SAMPLE

Immunohistochemical analysis of paraffin embedded human cancer tissue labelled with HGS-S303 at 1/1000 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

 

前沿进展

 
 
货号/价格
文档
联系电话:
+86 400-682-2521(全国)
010-53681107(北京)
021-50850665(上海)
运输方式
订单邮箱:
order.cn@acrobiosystems.com
技术支持邮箱:
tech.cn@acrobiosystems.com
C-MET靶点信息
英文全称:Hepatocyte growth factor receptor
中文全称:肝细胞生长因子受体
种类:Homo sapiens
上市药物数量:9详情
临床药物数量:61详情
最高研发阶段:批准上市
查看更多信息
前沿进展
点击查看详细

消息提示

请输入您的联系方式,再点击提交!

确定